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Arsenic exists in many chemical forms with
varying degrees of toxicity. The more inor-
ganic the form, the greater the virulence. For
example, arsenate (AsV) and arsenite (AsIII)
are known carcinogens (1–3). Methylated
arsenic compounds monomethyl arsonic acid
(MMA) and dimethyl arsinic acid (DMA) are
less toxic, and the organic arsenicals arsenobe-
taine (AsB) and arsenocholine (AsC), com-
monly found in seafood, are relatively
innocuous (4,5). Once these compounds are
ingested, they metabolize in different ways;
inorganic arsenic compounds are metabolized
to DMA and MMA, whereas AsB and AsC are
unchanged (4,5) and are evidenced by their
existence in urine. Speciation analysis, typically
involving the coupling of a liquid chromato-
graphic method to a highly sensitive detection
method with multielement capabilities, such as
inductively coupled plasma mass spectrometry
(ICP-MS), is necessary to provide information
about individual arsenic species.
Our goal was to employ a mobile phase
that would separate the aforementioned six
arsenic species in human urine in a single
chromatographic run (including the internal
standard) in a reasonable time period (< 30
min). An appropriate buffer that would con-
form to these criteria was selected. To have a
high sample throughput, it was also manda-
tory that the mobile phases not deposit a sig-
nificant amount of salt on the sampling
interface of the mass spectrometer.
There have been many studies involving
speciation by the coupling of ion-exchange
chromatography (IC) to ICP-MS (IC-ICP-
MS) (6,7); however, studies reported in the lit-
erature have employed two separate columns
(anionic and cationic). Using a single column
to separate the six aforementioned arsenic
species is difficult because AsC exists in
cationic form at most pH levels, whereas the
other five species can be made anionic by
adjusting the pH. Consequently, many studies
demonstrate only effective separation of five
arsenic species in food and urine using an
anion-exchange column, with AsB eluting at
the void volume (8–11). Other studies report
separation of six or more arsenic species on an
anion-exchange column in food and biologic
matrices but either report analysis time of
more than 1 hr (12) or do not employ a
rugged method useful for a larger number of
samples (13). One study reported the use of a
cation- and anion-exchange column in series
(14), with sodium carbonate as the mobile
phase. Our investigation of this buffer system
resulted in good separation but poor rugged-
ness. It also resulted in low sample throughput
because the analysis had to be stopped fre-
quently to clean the heavy salt deposits on the
ICP-MS sampling interface.
Tris acetate buffer was previously used in
our laboratory (with ICP-MS detection) to
resolve and to quantitate four arsenic species
(AsIII, AsV, DMA, and MMA) in drinking
water on an anion-exchange column (15). The
method demonstrated acceptable linearity, pre-
cision, and accuracy and was successfully
applied for analysis of hundreds of drinking
water samples. The mobile phase resulted in
negligible salt deposits on the ICP-MS inter-
face, enabling the routine analysis of a large
number of samples. For the urine studies, the
Tris acetate buffer separation method was mod-
iﬁed by adding a cation-exchange column in
series to the anion-exchange column to separate
cationic forms of arsenic species along with the
anionic forms. The separation was compared
with that obtained using ammonium carbonate
buffer with the same two columns in series.
The ammonium carbonate buffer system
demonstrated a signiﬁcant improvement over
the Tris buffer system and was selected for use
in the speciation of six arsenic species in urine.
A total of 262 urine samples (251 samples + 11
control samples) were analyzed for the six
arsenic species of interest using the ammonium
carbonate buffer system. The same samples
were also analyzed for their total arsenic con-
tent by ﬂow injection analysis (FIA) coupled to
ICP-MS, and the total and species data were
compared to assess the mass balance.
Materials and Methods
Ion chromatography. A Waters 600S controller
(Waters, Milford, MA) was used to operate a
metal-free 626 high-performance liquid chro-
matographic (HPLC) gradient pump (Waters)
as well as a 717 autosampler for the IC
(Waters). The cation- and anion-exchange
columns used were Hamilton PRP-X100 (10
µm, 4.1 × 250 mm i.d.) and PRP-X200 (10
µm, 4.6 × 150 mm) (Hamilton Co., Reno,
NV), respectively.
Periodic regeneration of the columns was
necessary (after every 75–100 samples) to
ensure reproducible performance of the sepa-
ration. The cation-exchange column was
back-flushed with 0.1 M nitric acid (Fisher
Scientiﬁc, Pittsburgh, PA) for approximately
1 hr followed by type I deionized water
(Hydro Services, Research Triangle Park,
NC). The anion-exchange column was back-
flushed with 0.1 M sodium hydroxide
(Fisher) for 1 hr, followed by deionized water
for 1 hr. The regeneration was necessary to
remove the heavy chloride buildup on the
column over time (which may contribute to
the formation of 40Ar35Cl).
Inductively coupled plasma mass spec-
trometry. A VG Elemental PQ-XR ICP-MS
instrument (VG Elemental, Winsford, UK)
equipped with a Meinhard concentric 
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Six arsenic species [arsenate, arsenite, arsenocholine, arsenobetaine, monomethyl arsonic acid, and
dimethyl arsinic acid] present in human urine were determined using ion-exchange chromatography
combined with inductively coupled plasma mass spectrometry (IC-ICP-MS). Baseline separation was
achieved for all six species as well as for the internal standard (potassium hexahydroxy antimonate V)
in a single chromatographic run of less than 30 min, using an ammonium carbonate buffer gradient
(between 10 and 50 mM) at ambient temperature, in conjunction with cation- and anion-exchange
columns in series. The performance of the method was evaluated with respect to linearity, precision,
accuracy, and detection limits. This method was applied to determine the concentration of these six
arsenic species in human urine samples (n = 251) collected from a population-based exposure assess-
ment survey. Method precision was demonstrated by the analysis of duplicate samples that were pre-
pared over a 2-year analysis period. Total arsenic was also determined for the urine samples using ﬂow
injection analysis coupled to ICP-MS. The summed concentration of the arsenic species was com-
pared with the measured arsenic total to demonstrate mass balance. Key words: arsenic, HPLC, ion
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Research | Articlesnebulizer and a water-cooled, Scott double-
pass spray chamber, which were purchased
from CPI (Santa Rosa, CA) was used for this
work. The forward power was 1,348 W, and
the coolant and auxiliary and nebulizer gas
flows were 16, 1.4, and 0.7 L/min, respec-
tively. Time-resolved data acquisition software
(PQ Vision version 4.0, VG Elemental) was
used to simultaneously monitor arsenic species
at m/z 75 and ArCl interference at m/z 77 as
well as any elements used for internal stan-
dards (antimony, m/z 121; indium, m/z 115).
Buffer reagents. The Tris buffer was pre-
pared by the addition of Tris (hydroxy-
methyl)aminomethane (Aldrich, Milwaukee,
WI) to deionized water and adjusting the pH
to 7 with glacial acetic acid (≥ 99.99%;
Aldrich). The ammonium carbonate buffer
was prepared by dissolving ammonium car-
bonate (J.T. Baker, Phillipsburg, NJ) in
deionized water. HPLC-grade methanol
(Fisher) was also used with the ammonium
carbonate mobile phase (6% vol/vol of total
mobile phase). Before use, all mobile phases
were ﬁltered through 0.45-µm ﬁlters (Alltech,
Deerfield, IL). The gradient programs used
for each buffer are summarized in the flow
charts in Figure 1.
Standards/samples. Four arsenic standards
were purchased, including sodium arsenate
(AsV; Pfaltz & Bauer Inc., Waterbury, CT),
arsenious oxide (AsIII; 99.999% purity; GFS
Chemical Inc., Powell, OH), MMA (97%
purity; Chem Service, West Chester, PA), and
cacodylic acid (DMA; 99% purity; Pfaltz &
Bauer, Inc.). William Cullen’s group at the
University of British Columbia synthesized
AsB and AsC, which are not commercially
available. A spectrometric-grade single-ele-
ment standard containing AsV (High Purity
Standards, Charleston, SC) was used for the
preparation of standards for the determination
of total arsenic by FIA-ICP-MS. Potassium
hexahydroxy antimonate V (Aldrich) was used
as the internal standard for speciation studies
and indium standard (High Purity Standards)
was used as the internal standard for the ﬂow
injection work.
A total of 262 samples (251 urine samples
+ 11 ﬁeld control samples) were made avail-
able for this study. The samples were collected
from 300 homes from different individuals as
part of the National Human Exposure
Assessment Survey study, conducted in U.S.
Environmental Protection Agency Region V
from July 1995 to May 1997 (16–18). Region
V consists of the Great Lakes area (Minnesota,
Wisconsin, Illinois, Indiana, Ohio, Michigan),
in which the demographic characteristics of the
population (e.g., races, ethnic groups, socioeco-
nomic distribution) are similar to the national
proﬁle (18). The samples were collected in 50-
mL polypropylene tubes and stored at 20°C.
Sample preparation. Speciation. Before
taking a 1-mL aliquot for speciation analysis,
samples were allowed to thaw to room tem-
perature in a class 100 hood and centrifuged.
The samples were then ﬁltered using a 0.2-µL
syringe ﬁlter into an autosampler vial, spiked
with the internal standard (potassium hexahy-
droxy antimonate V) and diluted 1:10 using
the mobile phase buffer before being injected
on to the chromatographic system.
Total arsenic. A ﬂow injection system with
the same controller, chromatograph, and
autosampler coupled to ICP-MS was used to
determine total arsenic concentration in urine
samples. Urine samples for this analysis were
diluted 1:10 with 1% (vol/vol) nitric acid and
spiked with 10 ng/mL indium before injection
into a 1% (vol/vol) nitric acid carrier stream.
Quality control: arsenic speciation. Each
day of sample analysis, the chromatographic
system was equilibrated with the starting
mobile phase, and deionized water was
injected to establish the background and to
verify that there was no arsenic carryover
from previous injections. National Institute
of Standards and Technology standard refer-
ence material (SRM 2670; normal level, toxic
metals in freeze-dried urine) was evaluated for
use as the matrix but was deemed unsuitable
because it contained a high level of arsenic
that was incompatible with the goal of
extending the arsenic linearity to low levels
(0.5 ng/mL). The concentration of arsenic in
SRM 2670, normal level, was 60 ng/mL,
which corresponds to 6 ng/mL with 1:10
dilution as deﬁned in the method. The daily
calibration standards (0.5, 1.0, 5.0, and 30
ng/mL) were prepared in a urine matrix col-
lected from individuals who had not con-
sumed seafood for 2–3 days before collection.
The urine was screened for arsenic before its
use as the control matrix, and the urine con-
taining the lowest arsenic was used for the
matrix. The samples were analyzed in batches
ranging from 10 to 15 per day. A duplicate
analysis of the same solution or duplicate
preparation of a sample was included with
each batch of samples. At the end of the day,
a predetermined mid-level calibration stan-
dard (continuous calibration check) was rean-
alyzed to verify the calibration and the
instrument performance.
Quality control: total arsenic analysis.
Calibration standards (ranging from 0.5 to 10
ng/mL) were prepared in 1% (vol/vol) nitric
acid. Each sample was injected 3 times into
the 1% (vol/vol) nitric acid carrier stream, and
the average of the three readings was used to
calculate the concentration of arsenic in the
sample. Duplicate injections and duplicate
preparations were analyzed daily along with
the continuous calibration check standard.
Data processing. The ICP-MS data for
each injected chromatographic run were col-
lected and then converted to ASCII format.
The chromatographic results were processed
using Grams/32 software (Galactic Industries
Corporation, Salem, NH). Final sample con-
centrations were calculated using the regres-
sion equations of measured response (peak
areas) versus concentration for each species of
arsenic.
Results
Selection of a mobile phase for speciation. In
our laboratory, a Tris acetate buffer gradient
was developed and successfully applied for the
speciation of four arsenic species (AsIII, AsV,
DMA and MMA, and internal standard) in
drinking water using IC-ICP-MS (15).
Consequently, this buffer was evaluated for
the separation of six species in urine. The sep-
aration was unsuccessful and resulted in
coeluting peaks for AsB and AsIII as well as
insufﬁcient baseline separation of MMA and
AsC (Figure 2).
An ammonium carbonate buffer mobile
phase was evaluated next for arsenic speciation
in urine, and a successful separation was
achieved for the six arsenic species and the
potassium hexahydroxy antimonate V internal
standard (Figure 3).
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Figure 1. Flow diagrams. (A) Tris acetate buffer gradient. (B) Ammonium carbonate buffer gradient. (A) a, 5
mM Tris acetate; b, 30 mM Tris acetate; c, 100 mM Tris acetate. Flow rate, 1.5 mL/min; injection volume,
200 µL; column temperature, 25°C. Detection, ICP-MS; column conﬁguration; PRP-X200 cation exchange
guard; PRP-X200 cation exchange column, PRP-X100 anion exchange column. (B) a, 94:6 (vol/vol) 10 mM
(NH4)2CO3:MeOH; b, 94:6 (vol/vol) 50 mM (NH4)2CO3:MeOH. Flow rate, 1.0 mL/min; injection volume, 200 µL;
column temperature, 25°C. Detection, ICP-MS; column configuration, PRP-X100 anion exchange guard,
PRP-X200 cation exchange column, PRP-X100 anion exchange column. 
20,000
15,000
10,000
5,000
0
05 1 0 15 20 25 30
A
r
s
e
n
i
c
 
s
i
g
n
a
l
 
i
n
t
e
n
s
i
t
y
 
(
c
p
s
)
Retention time (min)
1 + 2
3
4
5
6
Figure 2. Chromatogram of a 10-ppb calibration stan-
dard. Peak 1, AsB; peak 2, AsIII; peak 3, DMA; peak
4, MMA; peak 5, AsC; peak 6, AsV. Chromatographic
conditions: mobile phase, Tris acetate buffer at pH 7. 
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aMethod performance evaluation for arsenic
speciation in urine. The ammonium carbonate
buffer method performance was assessed by
determining linearity, precision, accuracy, and
detection limits for the six species in a urine
matrix. The matrix used consisted of urine
samples from several individuals who did not
consume seafood 2–3 days before collection.
The linearity for the six species was
demonstrated. Plots of normalized peak area
versus arsenic concentration for concentrations
ranging from 0.50 to 100 ng/mL were con-
structed using a 1/x2 weighted linear least-
squares regression for each arsenic species.
Method detection limits (MDLs) and method
quantitation limits (MQLs) were calculated for
each of the six species and are presented in
Table 1 along with the correlation coefﬁcients.
The values for MDL were calculated as 3 times
the standard deviation (SD), and MQL were
calculated as 10 times SD of three replicate
analyses of pooled urine spiked at 0.50 ng/mL
for each of the six species. The short-term (4-
hr) precision was demonstrated by the analysis
of a urine matrix fortiﬁed with three concen-
trations (0.5, 2.0, and 5.0 ng/mL) of all six
arsenic species (Table 2). The percent relative
SD (%RSD) was greatest for AsB at 0.5
ng/mL, most likely because of the relatively
high AsB concentration (0.5–1 ng/mL) found
in the urine matrix. The long-term precision
was demonstrated by a %RSD of ≤ 15% for
replicate analyses of urine fortified with 2.0
ng/mL of each species over a 3-day period
(Table 2). Accuracy was demonstrated by a
percentage bias ≤ 18% for all species through
the replicate analysis of urine fortiﬁed at three
different concentrations (0.5, 1.0, and 10.0
ng/mL), with the exception of AsB at 0.5
ng/mL (Table 3). Because the MQL for AsB is
0.5 ng/mL, this may account for the 60% bias.
Urine samples. Results for the determina-
tion of arsenic species in urine are presented
in Table 4. The ﬁeld controls were deionized
water samples subjected to the same sample
preparation steps as the urine samples. DMA
is the most commonly found arsenic species
and exists in the highest concentration for the
samples in this study.
After completion of sample analysis, eight
samples that contained the highest measurable
values of the ﬁve species (AsB, AsIII, DMA,
MMA, and AsV) were selected for reanalysis
to further evaluate the method. A second
aliquot of each was removed from the original
sample, prepared, and analyzed. Analysis peri-
ods varied as much as 3 months between the
duplicate samples (as presented in Table 5).
Urine samples were also analyzed for total
arsenic by FIA-ICP-MS. Because the urine
matrix contains a signiﬁcant level of chloride,
a correction equation was employed to
account for the contribution from 40Ar35Cl to
the 75As signal (19).
Discussion
The current reported method for determina-
tion of six arsenic species in urine using an
ammonium carbonate buffer resulted in
acceptable performance and significant
improvement over the existing methods
reported in the literature (6–14). The method
uses cationic and anionic columns in series
for complete baseline separation of six arsenic
species and the internal standard, in a single
chromatographic run of less than 30 min.
Method performance was demonstrated
using the ammonium carbonate buffer to
determine six arsenic species in urine. The cal-
culated detection limits are comparable and in
some cases superior to detection limits deter-
mined by other investigators (20–22). The use
of ammonium carbonate as a buffer resulted in
minimal salt deposit on the cones; thus, a high
throughput of samples was achieved despite
urine’s high chloride concentration. The lack of
salt deposition on the cones, as well as the infre-
quent column regeneration (every 75–100 sam-
ples), results in less instrument downtime and
thus less cost per sample. The method is also
rugged, as demonstrated through the duplicate
sample analysis results obtained over several
months. Finally, evaluation of species and total
arsenic data suggests that mass balance was
close and that the majority of arsenic species in
the urine were accounted for (Figure 4).
Additional improvements could be made.
Although the detection limits are similar or
superior to those in other studies reported in
the literature, further improvements in sensi-
tivity could lower the detection limits. It may
also be beneﬁcial to employ a “mixed-bed” sta-
tionary-phase column containing both cationic
and anionic elements instead of two columns
to perform the separation. This would reduce
the column regeneration time and possibly the
species separation time. An evaluation of addi-
tional arsenic species other than the aforemen-
tioned six may improve the mass balance.
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Table 1. Detection limits and correlation coefﬁcients.
Arsenic MDL MQL  Correlation
species (ng/mL)a (ng/mL)a coefﬁcient
AsB 1 4 0.9950
AsIII 0.2 0.8 0.9960
DMA 2 5 0.9940
AsC 1 5 0.9936
MMA 0.2 0.6 0.9970
AsV 2 5 0.9952
aValues based on species in undiluted urine.
Table 2. Short-term and long-term precision.
Arsenic Short-term (4-hr) precision (% RSD) Long-term (3-day) precision (% RSD)
species 0.50 ng/mL 1.00 ng/mL 5.00 ng/mL 2.00 ng/mL
AsB 4 5 4 6
AsIII 8 2 3 4
DMA 5 5 5 5
AsC 18 12 5 12
MMA 33 10 4 11
AsV 45 14 8 15
Table 3. Analysis results for the method accuracy.a
Method accuracy (% bias)
Arsenic 0.50 ng/mL 1.0 ng/mL 10 ng/mL
species (n = 3) (n = 3) (n = 5)
AsB 60 11 –3.0
AsIII 0 2.0 4.1
DMA 4.0 –10 –1.8
AsC –10 –4.0 –3.1
MMA 4.0 –5.0 1.3
AsV 18 –1.0 16
aCalculated as [(predicted concentration – nominal con-
centration)/(nominal concentration)] × 100.
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Figure 3. Chromatogram of a 10-ppb calibration standard. Peak 1, AsB; peak 2, AsIII; peak 3, DMA; peak 4,
AsC; peak 5, MMA; peak 6, AsV; IS, internal standard (potassium hexahydroxy antimonate V).
Chromatographic conditions: mobile phase (NH4)2CO3 buffer at pH 9.Trivalent MMA and DMA species were not
accounted for in this study. These species were
observed in human urine when sodium 2,3-
dimercapto-1-propane sulfonate was orally
administered to humans before collection of
their urine samples (22,23). Furthermore,
these species are reported to be unstable in
solution and are readily oxidized to their pen-
tavalent forms (referred to as DMA and MMA
in this study) (22).
In summary, this method is complemen-
tary to other speciation methods in the litera-
ture, with the primary advantage of being
rugged, which is highly desirable in exposure,
toxicology, and epidemiology studies that
generate large numbers of samples over a
long period of time. It is a viable choice for
speciation of arsenic species in urine.
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Table 4. Summary of arsenic species present in urine samples.
Sample type AsB (ng/mL) AsIII (ng/mL) DMA (ng/mL) AsC (ng/mL) MMA (ng/mL) AsV (ng/mL)
Field controls ND (n = 11)  ND (n = 11)  ND (n = 11)  ND (n = 11) ND (n = 11) ND (n = 11)
Field samples  ≤ 1,300–≥ 1000 ≤ 15.0–≥ 10.0 ≤ 60.0–≥ 10.0 ≤ 10.0–≥ 5.00 ≤ 10.0– ≥ 5.00 ≤ 10.0–≥ 5.00
(n = 1) (n = 3) (n = 19) (n = 2) (n = 7) (n = 8)
≤ 999–≥ 100 ≤ 9.99–≥ 2.00 ≤ 9.99–≥ 5.00 ≤ 4.99– ≥ 2.00 ≤ 4.99– ≥ 2.00 ≤ 4.99– ≥ 2.00
(n = 3) (n = 3) (n = 73) (n = 1) (n = 49) (n = 19)
≤ 99.9–≥ 10.0 ≤ 1.99–≥ 1.00 ≤ 4.99– ≥ 1.00 ≤ 1.99– ≥ 1.00 ≤ 1.99– ≥ 1.00 ≤ 1.99– ≥ 1.00
(n = 17) (n = 23) (n = 105) (n = 5) (n = 42) (n = 28)
≤ 9.99–≥ 0.01 ≤ 0.99– ≥ 0.02 ≤ 0.99– ≥ 0.01 ≤ 0.99– ≥ 0.01 ≤ 0.99– ≥ 0.01
(n = 63)  (n = 11)  (n = 17)  (n = 24) (n = 29)
ND ND ND ND ND ND
(n = 167)  (n = 211) (n = 37) (n = 243)  (n = 129) (n = 167)
Abbreviations: n, number of samples in the group; ND, not detected.
Table 5. Duplicate sample analysis results (ng/mL).
Sample AsB  AsIII  DMA  AsC  MMA  AsV 
UP0018 0.21, 0.25a(13)b 0.08, 0.15 (43) 1.04, 1.64 (32) ND 0.41, 0.48 (12) 0.46, 0.33 (22)
UP0076 ND ND ND ND 0.24, 0.23 (2.2)
UP0169 ND ND ND ND 0.52, 0.38 (23) 0.55, 0.44 (17)
UP0179 ND ND ND ND ND 0.56, 0.51 (6.3)
UP0188 ND 0.21, ND ND ND ND ND
UP0222 ND 0.25, 0.29 (12) 5.07, 6.72 (20) ND 0.55, 1.65 (71) ND
UP0225 128, 94.6 (21) ND 5.48, 4.44 (15) ND 0.29, 0.40 (23) 0.74, 0.23 (75)
UP0089 21.2, 19.2 (7.0) ND ND ND ND ND
aRepresents calculated concentrations for duplicate samples. bPercent RSD.
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Figure 4. Comparison of speciated arsenic versus
total arsenic.